<--- Back to Details
First PageDocument Content
Eye surgery / Blindness / Macular degeneration / Ranibizumab / Intraocular lens / Corneal transplantation / Visual acuity / Vascular endothelial growth factor / Cataract / Medicine / Vision / Ophthalmology
Date: 2012-07-05 16:13:38
Eye surgery
Blindness
Macular degeneration
Ranibizumab
Intraocular lens
Corneal transplantation
Visual acuity
Vascular endothelial growth factor
Cataract
Medicine
Vision
Ophthalmology

Add to Reading List

Source URL: www.nice.org.uk

Download Document from Source Website

File Size: 174,56 KB

Share Document on Facebook

Similar Documents

Targeting Vascular Endothelial Growth Factor Receptor 2 and Protein Kinase D1 Related Pathways by a Multiple Kinase Inhibitor in Angiogenesis and Inflammation Related Processes In Vitro

DocID: 1v2t4 - View Document

Targeting Notch/Delta-like ligand 4 (DLL4) and vascular endothelial growth factor (VEGF) pathways by an anti-DLL4/Anti-VEGF bi-specific monoclonal antibody inhibits tumor growth and reduces cancer stem cell frequency in

DocID: 1t4Bh - View Document

Co-Targeting of Delta-like ligand 4 (DLL4) and vascular endothelial growth factor A (VEGF) with Programmed Death 1 (PD1) blockade inhibits tumor growth and facilitates anti-tumor immune responses. Minu K. Srivastava, Chr

DocID: 1sS2d - View Document

Biology / Cell biology / Biotechnology / Chemical bonding / Breast cancer / RTT / Ribbon symbolism / Molecular imaging / Vascular endothelial growth factor / Ligand / C-Met / Cell culture

Theranostics 2016, Vol. 6, Issue 11 Ivyspring International Publisher Research Paper

DocID: 1qwzN - View Document

Biology / Biochemistry / Transcription factors / Gene expression / DNA / Bioinformatics / Molecular biology / TRANSFAC / DNA binding site / Biobase / Vascular endothelial growth factor / Promoter

APPLI CATI O N N O T E Exploring gene promoters for experimentally-proven and putative transcription factor binding sites with TRANSFAC® Professional and the included Match™ tool TRANSFAC® Professional is a unique k

DocID: 1q7G9 - View Document